FS Register FRN 1029698

Five Star Rated on Google

13+ years specialist broking experience

General information, not advice. Written for general guidance and drawing on external sources as well as our own experience. It isn't a personal recommendation and doesn't take account of your circumstances — full disclaimer and sources.

Weight Loss Clinic Insurance UK | GLP-1 & Mounjaro Cover

Weight Loss Clinic Insurance UK | GLP-1 & Mounjaro Cover

June 11, 2026
📅 11 June 2026 ⏱️ 22 min read 🏷️ Adverse Risk · Healthcare ✍️ By John Miller, Director & Principal Broker
Last reviewed by John Miller — 11 June 2026
FS RegisterFRN 1029698
13+ YearsSpecialist commercial
Lloyd's AccessSpecialist MGA schemes
UK-BasedSwansea & nationwide

Why do weight-loss and GLP-1 clinics need specialist insurance treatment?

The UK has become the largest anti-obesity medication market in Europe almost entirely on the back of private demand. Around 1.6 million UK adults used a weight-loss drug in the year to early 2025, and roughly two million now pay out of pocket — against a few hundred thousand on the NHS. Behind that demand sits a fast-growing layer of private weight-loss clinics, online pharmacies and GLP-1 prescribing services dispensing semaglutide (Wegovy) and tirzepatide (Mounjaro).

From an underwriter's chair, this is one of the hardest commercial risks to place in 2026 — and that difficulty is precisely why generic aesthetics and clinic insurance rarely fits. A weight-loss clinic carries a stack of overlapping exposures that standard markets are not built for: clinical negligence around prescribing decisions, professional indemnity for the assessment process, product liability tied to a medicine now flagged for a serious safety signal, and the reputational and regulatory fallout of a sector under intense scrutiny from the GPhC, MHRA and CQC. Many standard insurers simply decline.

Placing difficult, fast-moving healthcare risk like this is exactly what The Insurability Framework™ was built for. If your clinic has already been refused cover, or you are launching and want to get the structure right from day one, this guide explains what cover you actually need, how underwriters assess you, and what drives your premium. It sits alongside our wider adverse-risk insurance hub and our guide to aesthetics business insurance.

How we place weight-loss clinic risk: the Insurability Framework

GLP-1 clinics are a textbook "difficult risk" — high public demand, sharpening regulation and a live drug-safety signal. We approach every placement through four pillars rather than firing your details at a panel and hoping.

01

Underwriter Intelligence

We know what triggers concern on a weight-loss clinic — questionnaire-only prescribing, no BMI verification, no prescriber oversight — and how to evidence the controls that move you from "decline" to "quote".

02

Difficult Risk Expertise

When mainstream insurers avoid GLP-1 and medical-weight-loss exposures, we place them through specialist medical malpractice and Lloyd's-backed facilities built for exactly this kind of clinical risk.

03

Risk Assessment

We surface the hidden exposures that sink applications: off-licence indication creep, supply from unverified sources, weak record-keeping, and the gap between your PI and your medical malpractice cover.

04

Claims Advocacy

If a pancreatitis claim or a GPhC complaint lands, you deal with real people who fight your corner — not a call centre. We coordinate insurers, defence solicitors and your regulatory response.

Key facts at a glance

  1. The UK private weight-loss medication market is worth roughly £210 million a year and grew about 56% in a single year, with over two million adults paying privately.
  2. On 29 January 2026 the MHRA updated GLP-1 product information and issued a drug safety alert over the risk of severe acute pancreatitis — a live exposure underwriters now price for.
  3. Between 2007 and October 2025 the MHRA received 1,296 Yellow Card reports of pancreatitis linked to GLP-1 medicines, of which 19 were fatal.
  4. The GPhC tightened its guidance on online prescribing of weight-management medicines, so a simple questionnaire is no longer enough — providers must carry out a fuller clinical assessment.
  5. A weight-loss clinic typically needs medical malpractice cover in addition to professional indemnity — the two are not the same, and a gap between them is a common claim trap.
  6. Clinics providing a "regulated activity" generally need CQC registration in England (with equivalents in Wales, Scotland and Northern Ireland) — uninsured regulatory exposure if missed.
  7. Many standard insurers decline GLP-1 clinics outright, so cover is usually arranged through specialist medical and Lloyd's facilities — a broker's market, not a comparison-site one.
£210mUK private weight-loss meds market per year
1,296Yellow Card pancreatitis reports to Oct 2025
~2mUK adults paying privately for GLP-1s
56%One-year growth in the private market

What does weight-loss clinic insurance actually cover?

"Weight-loss clinic insurance" is not a single product — it is a package assembled from several covers, the mix depending on whether you prescribe, dispense, administer, or simply consult. The error we see most often is a clinic relying on a standard clinic or beauty policy that quietly excludes prescribing and medication-related claims. Here is how the core covers differ and why each matters for a GLP-1 service.

CoverWhat it protects againstWhy a GLP-1 clinic needs it
Medical Malpractice Clinical negligence — a prescribing or treatment decision that causes patient harm Essential. Covers the clinical act of prescribing/administering GLP-1s. PI alone usually will not.
Professional Indemnity Negligent advice, assessment errors, breach of professional duty Essential. Covers the consultation, eligibility assessment and aftercare advice. See our PI cover guide.
Product Liability Harm caused by a product you supplied — including medicines and devices Essential. Critical given the live pancreatitis signal and supply-chain risk. Links closely to product recall cover.
Public Liability Third-party injury or property damage on your premises Essential. Standard for any clinic with patient footfall.
Employers' Liability Injury or illness to staff Legally required if you employ anyone (£5m minimum).
Cyber & Data Breach of patient health records, ICO action, ransomware Strongly recommended. Clinics hold special-category health data. See cyber insurance.
The PI / medical malpractice gap is the classic claim trap Professional indemnity and medical malpractice are not interchangeable. A claim that a patient was harmed by the GLP-1 itself (a clinical/treatment claim) can fall outside a pure PI wording, while a claim about negligent advice can fall outside a treatment-focused policy. We make sure both triggers respond and that there is no daylight between them.

Only one cover is a statutory must-have for most clinics: Employers' Liability, required by the Employers' Liability (Compulsory Insurance) Act 1969 if you employ staff, with a £5m minimum and fines for non-compliance. Everything else is "commercially essential" rather than legally mandated — but in practice you cannot run a credible, contractable GLP-1 clinic without medical malpractice, PI and product liability in place, and many landlords, platforms and pharmacy wholesalers will require evidence of cover before dealing with you.

From recent placement conversations

The most difficult conversations I have are with founders who scaled a weight-loss service fast on questionnaire-only prescribing, then discovered at renewal that their original policy never properly covered the medication side at all. By then the GPhC guidance had moved, an insurer had asked questions they couldn't answer, and they were facing a decline. Getting the clinical governance and the cover structure right early is far cheaper than fixing it under pressure.

What cover does your type of weight-loss business need?

The right package depends on your model. Select the closest match to see the cover stack we would typically build — and where specialist placement is usually needed. For tailored cover, start with a weight-loss clinic quote.

Cover Checker

In-person GLP-1 prescribing clinic

Essential
Medical malpractice — covers the clinical prescribing and administration decision.
Essential
Professional indemnity — eligibility assessment, contraindication screening and aftercare advice.
Essential
Product liability — harm linked to the medicine supplied.
Legal
Employers' liability — required if you have staff.
Recommended
Public liability + cyber/data — footfall and special-category health records.
Specialist placement
Most standard markets decline this profile — it usually needs a specialist adverse-risk broker.

Online pharmacy / remote prescriber

Critical
Remote prescribing exposure — the GPhC now expects a fuller clinical assessment than an online form. Underwriters price heavily on this.
Essential
Medical malpractice + PI — the assessment and prescribing decisions are made remotely and at volume.
Essential
Product liability + cyber — dispensing-at-scale and large patient databases.
Recommended
Management liability / D&O — regulatory investigations against directors.

Aesthetic clinic adding weight-loss jabs

Critical
Notify your insurer before you start. Adding prescribing to an aesthetics policy is a material change — failing to disclose can void cover.
Essential
Medical malpractice extension — your existing aesthetics cover likely won't reach GLP-1 prescribing.
Recommended
Review alongside other treatment lines such as IV drip therapy.

Pharmacist-led weight-management service

Essential
Professional indemnity for pharmacy practice plus product/dispensing liability.
Recommended
Medical malpractice where independent prescribing is involved.
Consider
Stock and contents cover for cold-chain medicine storage.

Coaching / non-prescribing programme

Essential
Professional indemnity + public liability for advice and contact.
Consider
Product liability if you sell supplements — see nutrition products cover.
Watch
The moment you facilitate access to prescription medicines, your risk profile jumps into the clinical category above.

Multi-site / scaling group

Essential
Group medical malpractice + PI with adequate aggregate limits across sites.
Essential
Management liability / D&O — directors face personal exposure in a regulated, scrutinised sector.
Recommended
Cyber at portfolio scale and business interruption — see commercial insurance hub.

Is your clinic compliant enough to be insurable?

Insurability and clinical governance are now the same conversation. Tick the controls you already have in place — each one strengthens your application; each red flag is a question an underwriter will ask before quoting.

Insurability & compliance checklist

  • ✓
    Prescribing is by a GMC/GPhC-registered independent prescriber following a full clinical assessment (not questionnaire-only).
  • ✓
    BMI and medical history are verified, with safeguards against patients faking eligibility.
    Red flag if missing
  • ✓
    Patients are counselled on pancreatitis warning signs in line with the MHRA's January 2026 alert.
    Red flag if missing
  • ✓
    Medicines are sourced only from licensed UK wholesalers — never grey-market or unverified suppliers.
    Red flag if missing
  • ✓
    CQC registration (or devolved equivalent) is held where a regulated activity is provided.
  • ✓
    Full, auditable patient records and consent are kept for every prescription.
  • ✓
    Adverse reactions are reported via the MHRA Yellow Card scheme.
  • ✓
    You hold both medical malpractice and PI, with no gap between treatment and advice claims.
0 of 8 controls in place — tick the boxes that apply to see where you stand.

How high-risk is your weight-loss clinic to an underwriter?

This quick assessor mirrors how a specialist underwriter triages a GLP-1 clinic. Pick your prescribing model and your governance maturity for an indicative risk tier — and what it usually means for placement.

Risk Assessor

Weight Loss Clinic Insurance
Weight Loss Clinic Insurance

How do GPhC and MHRA rules affect your insurability?

Underwriters do not assess a weight-loss clinic in a vacuum — they assess it against the regulatory expectations the clinic must meet. Two bodies dominate that picture. The General Pharmaceutical Council (GPhC) regulates pharmacies and pharmacy professionals, and has tightened its guidance on online prescribing of weight-management medicines: a simple online questionnaire is no longer acceptable, and providers are expected to carry out a fuller clinical assessment with independent verification of patient information. The medicines themselves are now treated as high-risk, requiring stricter safeguards before a private prescription is issued.

The Medicines and Healthcare products Regulatory Agency (MHRA) licenses the medicines and runs the safety-monitoring system. Prescribing must comply with the Human Medicines Regulations 2012, and prescribers must be appropriately registered with the GMC, GPhC or other statutory regulator. For an insurer, evidence that you operate inside this framework — registered prescribers, full assessments, licensed supply, Yellow Card reporting — is the difference between a quote and a decline. Where a clinic has already fallen foul of these expectations, placement moves firmly into adverse-risk territory.

Do you need CQC registration to run a weight-loss clinic?

In England, providing a "regulated activity" — which can include the prescribing or supply of medicines as part of a clinical service — generally requires registration with the Care Quality Commission (CQC) under the Health and Social Care Act 2008. Equivalent regulators apply in the devolved nations (Healthcare Inspectorate Wales, Healthcare Improvement Scotland, and the RQIA in Northern Ireland). Whether your specific model triggers registration depends on exactly what you do and who does it — this is a question for your regulatory adviser, not your broker — but from an insurance standpoint the principle is simple: operating a registrable activity without registration is an uninsured regulatory exposure, and most insurers will ask to see your registration position before quoting. We share guidance on the clinic registration dimension in our ADHD clinic insurance guide, which deals with the same CQC themes.

Why is the pancreatitis safety signal changing underwriting?

On 29 January 2026 the MHRA updated GLP-1 product information and issued a drug safety alert highlighting the risk of severe acute pancreatitis, urging clinicians to counsel patients on the warning signs and to stop the medicine immediately if pancreatitis is suspected. Between 2007 and October 2025 the agency received 1,296 Yellow Card reports of pancreatitis linked to GLP-1 or dual GLP-1/GIP receptor agonists, of which 19 were fatal and 24 involved necrotising forms. The MHRA and Genomics England have launched a Yellow Card Biobank study into whether genetics influence who is most at risk.

For underwriters, a live, regulator-flagged safety signal attached to the very product your business revolves around is a material change in the risk landscape. It raises the realistic prospect of clinical-negligence and product-liability claims alleging that a clinic failed to assess, warn or monitor appropriately. That is why medical malpractice and product liability — and the documented governance behind your prescribing — now carry far more weight in pricing than they did even a year ago.

What strengthens your position Counselling patients on pancreatitis symptoms, recording that counselling, screening for contraindications, and reporting suspected reactions via the Yellow Card scheme are not just clinical best practice — they are the evidence that defends a claim and reassures an underwriter.

How does the illegal-supply market affect product liability?

Soaring demand has created a parallel illegal market. Across 2025 the MHRA seized close to 20 million doses of illegal weight-loss and diabetes products worth around £45 million, and Border Force intercepted tens of thousands more. Reports have also emerged of patients faking their weight or medical history to obtain prescriptions. For a clinic, both trends carry direct insurance consequences: sourcing stock from anything other than licensed UK wholesalers exposes you to product-liability and counterfeit claims that insurers will not entertain, and weak eligibility verification undermines the clinical-assessment defence at the heart of any negligence claim. The integrity of your supply chain and your assessment process is, in effect, an underwriting question — closely related to the issues we cover in product recall insurance.

What drives the cost of weight-loss clinic insurance?

There is no single "price" for a GLP-1 clinic — premiums are built from your specific risk profile. These are the factors that move your premium most, and the practical steps that pull it back down. Because most standard markets decline this class, the realistic comparison is not "cheap versus expensive" but "placeable versus uninsurable".

Rating factorWhy it affects your premiumHow to mitigate it
Prescribing modelRemote, questionnaire-led prescribing is rated far higher than in-person assessment.Use full clinical assessment; add video/ID verification for remote services.
Clinical assessment depthThin assessment is the single biggest negligence exposure.Document a structured assessment exceeding GPhC minimums.
Prescriber credentialsUnsupervised or thinly qualified prescribers raise concern.Use registered independent prescribers with clear oversight.
Patient volumeHigher throughput multiplies claim frequency exposure.Match limits and aggregates to realistic volumes.
Supply chainGrey-market or unverified supply is largely uninsurable.Source only from licensed UK wholesalers; keep audit trails.
CQC / regulatory statusMissing registration is an uninsured exposure.Confirm and evidence registration before applying.
Claims & complaints historyPrior claims or regulatory action sharply raise pricing.Disclose fully; show remediation — see our claims-history guide.
Record-keeping qualityPoor records weaken every defence.Keep auditable consent, prescribing and aftercare records.
Limit of indemnityHigher limits cost more but contractors/landlords often require them.Right-size limits to genuine exposure, not guesswork.
Number of sitesMulti-site groups carry aggregated exposure.Structure a group programme with adequate aggregate limits.
Data & cyber exposureLarge stores of special-category health data attract breach risk.Hold cyber cover and demonstrable data controls.
Adverse-event monitoringNo pancreatitis counselling or Yellow Card process is a red flag.Embed MHRA-aligned monitoring and reporting.
Indication / off-licence creepPrescribing outside licensed criteria escalates risk dramatically.Prescribe within licence; document any clinical justification.
Marketing & advertisingNon-compliant promotion of prescription medicines invites regulatory and liability claims.Keep advertising within MHRA and ASA rules.

What do real weight-loss clinic claims look like?

These fictionalised but realistic examples show how claims actually unfold in this sector — and what made the difference between a defended position and an expensive one.

Medical malpractice & PI

The questionnaire-only assessment

A remote prescribing service issued a tirzepatide prescription on the strength of an online form. The patient — who had under-reported a history of gallstones — developed acute pancreatitis and required hospital treatment. The subsequent claim alleged that the clinic's assessment was inadequate and failed to identify a contraindication or warn of symptoms.

£140,000Settlement
£68,000Defence costs
£208,000Total
Lesson: the defence turned on documentation that didn't exist. A structured clinical assessment with verified history and recorded pancreatitis counselling would have changed the outcome. Renewal impact: premium rose around 60% with tightened assessment warranties imposed.
Product liability

The unverified supplier

To manage a stock shortage, a clinic bought pens from a broker it had not used before. Some product turned out to be outside the licensed cold chain and a batch was implicated in adverse reactions. Affected patients brought a product-liability claim, and the clinic's insurer initially questioned cover because supply provenance could not be evidenced.

£95,000Claims paid
£40,000Investigation & legal
£135,000Total
Lesson: supply-chain integrity is an insurance issue, not just an operational one. Licensed-wholesaler-only sourcing with full audit trails keeps product-liability cover intact. Renewal impact: a strict licensed-supply warranty was added as a condition of continued cover.
Cyber & data breach

The exposed patient database

A scaling online weight-loss service suffered a ransomware attack that exposed special-category health records for several thousand patients. The incident triggered an ICO notification, patient claims, forensic costs and significant business interruption while systems were rebuilt.

£180,000Response & BI
£55,000Claims & legal
£235,000Total
Lesson: clinics are data businesses as much as clinical ones. Cyber cover and demonstrable data controls absorbed a loss that would otherwise have been existential. Renewal impact: cyber retained with improved controls; multi-factor authentication made a condition.

How should you handle a weight-loss clinic insurance claim?

If a clinical, product or regulatory issue arises, the first hours matter. This is the process we walk our clients through — and the order is deliberate.

  1. Act on patient safety first. Address the patient's clinical needs immediately and document every action you take.
  2. Notify your insurer at once. Most clinic policies are claims-made, so a claim or even a circumstance must be reported promptly — late notification can void cover.
  3. Do not admit liability. Be compassionate, but avoid admissions or apologies implying legal fault until insurers and solicitors have advised.
  4. Preserve all records. Secure the patient file, consent forms, prescribing records, supply documentation and communications before anything is changed.
  5. Report adverse drug reactions. Submit a Yellow Card report to the MHRA where a suspected adverse reaction is involved.
  6. Engage the regulator carefully. Coordinate any GPhC, CQC or GMC response with insurer-appointed solicitors to protect your position.
  7. Cooperate with the appointed defence. Work with panel solicitors and medical experts to build the defence and quantify the claim.
  8. Review and strengthen governance. Once resolved, close the gaps the claim exposed — it protects your next renewal and reduces recurrence.
John Miller, Director and Principal Broker at Miller & Partner, weight loss and GLP-1 clinic insurance specialist

John Miller

Director & Principal Broker — Miller & Partner Limited

John has 13+ years' specialist commercial insurance experience, with direct access to the Lloyd's market and specialist medical MGA schemes. He places difficult and adverse-risk healthcare exposures — including weight-loss, GLP-1 and medical-aesthetic clinics — that standard insurers decline. Read more about John.

Glossary of key terms

GLP-1 receptor agonist
A class of medicine that mimics the GLP-1 hormone to regulate appetite and blood sugar; used for weight management and type 2 diabetes.
Semaglutide (Wegovy)
A GLP-1 medicine licensed for weight management in the UK.
Tirzepatide (Mounjaro)
A dual GLP-1/GIP medicine licensed for weight management, dominant in the UK private market.
Medical malpractice insurance
Cover for clinical negligence — harm caused by a treatment or prescribing decision.
Professional indemnity (PI)
Cover for negligent advice, assessment or breach of professional duty.
Product liability
Cover for harm caused by a product you supplied, including medicines.
Claims-made basis
A policy that responds to claims made during the policy period, regardless of when the act occurred — hence the importance of prompt notification and run-off.
Independent prescriber
A registered professional permitted to prescribe within their competence without a doctor's sign-off.
Regulated activity
An activity (such as certain medicine supply) that requires CQC registration under the Health and Social Care Act 2008.
Yellow Card scheme
The MHRA's system for reporting suspected adverse drug reactions and device incidents.
Off-licence (off-label) prescribing
Prescribing outside the medicine's licensed indications — a material risk-rating factor.
Material fact
Information that would influence an insurer's decision; non-disclosure can void cover under the Insurance Act 2015.
Aggregate limit
The maximum an insurer will pay across all claims in a policy period.
Run-off cover
Continued claims-made cover after a business or activity ceases — vital for clinical risks.
Special category data
Sensitive personal data, including health records, given heightened protection under UK GDPR.
GPhC
General Pharmaceutical Council — regulator of pharmacies and pharmacy professionals.
MHRA
Medicines and Healthcare products Regulatory Agency — UK medicines and devices regulator.

Weight-loss clinic insurance FAQs

Do I need medical malpractice insurance as well as professional indemnity?
In almost all cases, yes. Professional indemnity covers negligent advice and assessment, while medical malpractice covers the clinical treatment or prescribing act itself. A GLP-1 clinic faces both exposures, and a gap between the two policies is a common and avoidable claim trap.
Why do standard insurers decline weight-loss clinics?
GLP-1 prescribing combines clinical negligence, product liability and regulatory exposure around a medicine now carrying a live safety signal. Most standard markets are not built for this risk and decline it, so cover is usually arranged through specialist medical and Lloyd's-backed facilities via a broker.
Does my clinic need CQC registration?
If you provide a regulated activity in England — which can include prescribing or supplying medicines as part of a clinical service — you generally need CQC registration under the Health and Social Care Act 2008, with equivalents in the devolved nations. Whether your model triggers it depends on what you do; confirm your position with a regulatory adviser, as insurers will ask about it.
How does the MHRA pancreatitis alert affect my cover?
The MHRA's January 2026 alert about severe acute pancreatitis is a regulator-flagged safety signal attached to the core product. Underwriters now weight medical malpractice and product liability more heavily, and expect to see pancreatitis counselling, contraindication screening and Yellow Card reporting in your governance.
Is questionnaire-only online prescribing still insurable?
It is the hardest model to place. The GPhC now expects a fuller clinical assessment than a simple form, and questionnaire-only services are rated as high-risk. Adding video or ID verification and a structured assessment materially improves both your compliance position and your insurability.
What limit of indemnity should a weight-loss clinic carry?
It depends on your patient volume, the contracts or platforms you work with, and your appetite for exposure. We size limits to genuine risk rather than guesswork — many clinics carry several million in medical malpractice and PI, with product and cyber alongside.
Does product liability cover the GLP-1 medicines I supply?
A correctly structured product-liability section responds to harm linked to product you supplied — provided that product came through a licensed UK supply chain. Stock from unverified or grey-market sources is generally uninsurable, which is why supply provenance is an underwriting question.
What happens to my cover if I close the clinic?
Because clinical policies are usually claims-made, claims can arrive after you stop trading. Run-off cover keeps you protected for past acts once the activity ceases — an essential consideration when winding down or selling, as explained in our run-off guide.
I have already been refused cover — can I still get insured?
Often, yes. A refusal usually reflects a market that doesn't write the class or a governance gap, not that the risk is uninsurable. A specialist adverse-risk broker can reposition the risk, evidence your controls and access markets that write it. See our guide to insurance for businesses refused cover.
Does the cover include cyber and patient data protection?
Not automatically — cyber is usually a separate section. Given clinics hold special-category health data, we strongly recommend cyber cover with demonstrable controls; a data breach is one of the most common large losses in this sector.
How much does weight-loss clinic insurance cost?
There is no fixed price — premiums are built from your prescribing model, governance, volume, supply chain, limits and claims history. The realistic question is placeable versus uninsurable; strong governance and licensed supply are what move you toward competitive terms.
Why use a specialist broker for a GLP-1 clinic?
This is a broker's market, not a comparison-site one. A specialist broker knows which insurers write the class, what evidence they want, and how to present your risk. Miller & Partner places weight-loss and GLP-1 clinic cover through the Insurability Framework and direct access to specialist medical and Lloyd's facilities.
Back to Blog
About this article General information, not advice. Published for general guidance and drawing on external sources as well as our own experience. It is not a personal recommendation, a quotation, or an offer of cover, and it doesn't take account of your circumstances. Read more + Close −

Where the information comes from

Our articles are compiled from a range of sources: regulators and public bodies such as the FCA, the Civil Aviation Authority, the Health and Safety Executive and Companies House; government publications and legislation; industry and trade bodies; insurer and market documentation; and published research and news reporting. Not everything stated originates from Miller & Partner. Where information comes from a third party we believe it to be accurate at the date of publication, but we haven't independently verified every external source and we don't warrant its accuracy or completeness. Where a point matters to a decision you're making, go to the original source and check it.

Figures, examples and case studies

Premium ranges, cost figures, limits and worked examples are illustrative only. They are not quotations, not offers of cover, and no cover is provided or implied on the basis of them. What you're actually charged depends on underwriting, and what you're actually covered for depends on the policy wording issued to you. Where an article includes a claim example, scenario or case study, it is illustrative unless we say otherwise — such examples are typically composites written to show how a policy section responds, and they don't describe an identifiable client, claim or settlement.

Interactive tools

Any calculators, cover checkers, risk assessors or similar tools on our site produce general guidance from the small number of answers you give them. They can't see your business, and their output is not a personal recommendation, an assessment of your actual risk, or a quotation.

Rules and market conditions change

Law, regulation, tax treatment, insurer appetite and policy wordings all change, sometimes at short notice. Content is accurate to the best of our knowledge on the date shown on the article and we don't undertake to update it as things move. An article you're reading some time after publication may be out of date.

Third parties and external links

References to insurers, underwriters, trade bodies, software, training providers or other organisations are for information only. They don't imply endorsement, recommendation, partnership or affiliation in either direction unless stated. We're not responsible for the content of external websites we link to.

Not legal, tax or accounting advice

Nothing here is legal, tax, accounting or regulatory advice. Where an article discusses statutory duties, contract terms or compliance obligations, take advice from an appropriately qualified professional on your own position before acting.

How we write these

We use AI tools in researching and drafting our published content. Every article is reviewed and signed off by a named, accountable person at Miller & Partner before it is published, and responsibility for what appears here rests with us.

Our regulatory status

Miller & Partner Ltd is an Appointed Representative of Gauntlet Risk Management Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 308081). Miller & Partner Ltd is entered on the FCA Register under reference 1029698. Registered in England and Wales, company number 16206282. Registered office: Vivian House, Roman Bridge Close, Mumbles, Swansea, SA3 5BG.

Spotted something wrong?

We'd rather know. Email [email protected] or call 01792 001350 and we'll review and correct it.

For advice on your own insurance arrangements, speak to us directly — that's when we can take your circumstances into account and give you a recommendation.

Ready to protect your business?
Get expert advice and a tailored commercial insurance quote today.

✔ Independent broker
✔ Access to leading UK insurers
✔ Fast turnaround

[Request a quote]

[[email protected]]
[Call 01792 001350]

Exclusive Offer

Free Insurance Review
& Zero Broker Fee

Let us review your current insurance and see if we can improve your cover while reducing the cost.

✓
Free no-obligation insurance review tailored to your business
£
Zero broker fee on all new policies
⚡
Fast response from a real insurance specialist

You're in 🎉

Thanks for requesting your free review. We'll be in touch shortly.

🔒 No spam, ever. Your details are safe with us.

We're an Appointed Representative of Gauntlet Risk Management Ltd, which is authorised and regulated by the FCA. You can check our entry on the FCA Register.

MEET THE Director

Hey, I'm John!

I started Miller & Partner with the aim to bring back personable, approachable broking to UK businesses who were tired of large corporate brokers and feeling like they were just another number.

I have built this brokerage up with no pushy sales techniques or big business tactics, just honest, approachable and professional relationships with my clients.

Over 13 years experience in business insurance

Client first approach

5* rated broker on Google

Office: Vivian House, Roman Bridge Close, Mumbles, Swansea, SA3 5BG

Miller & Partner Ltd is an Appointed Representative of Gauntlet Risk Management Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 308081). Miller & Partner Ltd is entered on the Financial Services Register under firm reference number 1029698. You may check this on the Financial Services Register by visiting the FCA website at https://www.fca.org.uk/firms/financial-services-register or by contacting the FCA on 0800 111 6768. Miller & Partner Ltd is registered in England & Wales, company number 16206282. Registered office: 20 Vivian House, Roman Bridge Close, Swansea, SA3 5BG.